SCHEMBL5957066

SCHEMBL5957066

Cc1cn(-c2ccc(Cl)c(C(=O)NC(O)C3CCCCCC3)c2)c(=O)n1CC(=O)NCC1CC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RX7 Q99572 6/20 0.45
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
RAB9A P51151 2/20 0.35
MITF O75030 1/20 0.35
ALDH1A1 P00352 1/20 0.35
LMNA P02545 1/20 0.35
MAPT P10636 1/20 0.35
HTT P42858 1/20 0.35
RECQL P46063 1/20 0.35
MDM2 Q00987 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
NPC1 O15118 1/20 0.34
CNR1 P21554 3/20 0.33
XPA P23025 1/20 0.33
AVPR1B P47901 1/20 0.33
F2 P00734 1/20 0.33
PRSS1 P07477 1/20 0.33
CNR2 P34972 4/20 0.33
CRHR1 P34998 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5837231 0.92 P2RX7 (0.39) P2RX7MEN1KMT2ACNR1CNR2
SCHEMBL5957156 0.90 P2RX7 (0.38) P2RX7ALDH1A1MAPTCNR1CNR2
SCHEMBL5838688 0.88 P2RX7 (0.39) P2RX7KMT2AALDH1A1HTTCNR1
SCHEMBL5837096 0.88 P2RX7 (0.39) P2RX7MAPTCNR1CNR2
SCHEMBL6277608 0.86 P2RX7 (0.35) P2RX7LMNACNR1CNR2
SCHEMBL5838779 0.86 P2RX7 (0.38) P2RX7MAPTCNR1CNR2
SCHEMBL5838492 0.86 ALDH1A1 (0.37) P2RX7MEN1KMT2AALDH1A1MAPT
SCHEMBL5838229 0.86 KMT2A (0.38) P2RX7KMT2AALDH1A1HTTAVPR1B
SCHEMBL5838488 0.85 P2RX7 (0.39) P2RX7MEN1KMT2AALDH1A1MAPT
SCHEMBL5957132 0.85 P2RX7 (0.46) P2RX7MEN1KMT2ARAB9AMITF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060217430-A1 Benzamide inhibitors of the P2X7 receptor DOMBROSKI MARK A 2006-09-28 US disclosed
EP-1581507-A1 BENZAMIDE INHIBITORS OF THE P2X7 RECEPTOR Pfizer Products Inc. (US) 2005-10-05 EP disclosed
WO-2004058731-A1 BENZAMIDE INHIBITORS OF THE P2X7 RECEPTOR PFIZER PRODUCTS INC. (US) 2004-07-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060217430-A1 Benzamide inhibitors of the P2X7 receptor IL1R1, P2RY1, P2RX1 P2RX7 7/4885MEN1 2987/4885KMT2A 3644/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.